Annual report pursuant to Section 13 and 15(d)

Acquisition of Ohr Pharmaceutical, Inc. - Consideration (Details)

v3.19.3.a.u2
Acquisition of Ohr Pharmaceutical, Inc. - Consideration (Details)
Jul. 12, 2019
USD ($)
$ / shares
shares
Acquisition of Ohr Pharmaceutical, Inc.  
Number of shares of the combined company to be owned by Ohr security holders | shares 2,829,248
Fair value per share of Ohr common stock as of July 11, 2019 | $ / shares $ 4.14
Fair value of Ohr shares outstanding $ 11,713,087
Fair value of options assumed 63,840
Fair value of common stock and options issued 11,776,927
Transaction costs 884,981
Total cost of the Ohr acquisition $ 12,661,908